Your browser doesn't support javascript.
loading
A Case of Prostate Cancer Harboring Androgen Receptor T878A Progesterone-Responsive Mutant Emerging After Abiraterone Acetate Treatment Responding to Darolutamide.
Varkaris, Andreas; Stevens, Julia; Ono, Yuho; Balk, Steven P; Bellmunt, Joaquim.
Affiliation
  • Varkaris A; Division of Hematology-Oncology, Department of Medicine, and Cancer Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
  • Stevens J; Division of Hematology-Oncology, Department of Medicine, and Cancer Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
  • Ono Y; Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School. Boston, MA.
  • Balk SP; Division of Hematology-Oncology, Department of Medicine, and Cancer Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
  • Bellmunt J; Division of Hematology-Oncology, Department of Medicine, and Cancer Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
JCO Precis Oncol ; 6: e2100091, 2022 02.
Article in En | MEDLINE | ID: mdl-35201849
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Receptors, Androgen Limits: Humans / Male Language: En Journal: JCO Precis Oncol Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Receptors, Androgen Limits: Humans / Male Language: En Journal: JCO Precis Oncol Year: 2022 Document type: Article Country of publication: